Wnt pathway is involved in advanced gastric carcinoma

Hepato-Gastroenterology

Volumn 55, Issue 84, 2008, Pages 1126-1130

  Zhang, Hongfeng ^a   Xue, Yingwei ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

catenin; E cadherin; Gastric carcinoma; Wnt 1

Indexed keywords

BETA CATENIN; UVOMORULIN; WNT1 PROTEIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HOSPITALIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CARCINOMA; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; BETA CATENIN; CADHERINS; CARCINOMA, SIGNET RING CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; SIGNAL TRANSDUCTION; STOMACH; STOMACH NEOPLASMS; WNT1 PROTEIN;

EID: 47149111867     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kirkoshi H, Katoh M: Expression and regulation of WNT10B in human cancer: up-regulation of WNT10B in MCF-7 cells by beta-estradiol and down-regulation of WNT10B in NT2 cells by retinoic acid. Int J Mol Med 2002; 10:507-511.
2. Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio-Preiser C, et al: β-catenin Mutation Is a Frequent Cause of Wnt Pathway Activation in Gastric Cancer. Cancer Res 2002; 62:3503-3506.
3. Lo Muzio L, Pannone G, Staibano S, Mignogna MD, Grieco M, Ramires P, et al: Wnt-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin. Anticancer Res 2002; 22:565-576.
4. Watanabe O, Imamura H, Shimizu T, Kinoshita J, Okabe T, Hirano A, et al: Expression of twist and wnt in human breast cancer. Anticancer Res 2004; 24:3851-3856.
5. Miller JR: The Wnts. Genome Biol 2002; 3:REVIEWS3001.
6. Khor TO, Gul YA, Ithnin H, Seow HF: A comparative study of the expression of Wnt-1, WISP-1 survivin and cyclin-D1 in colorectal carcinomas. Int J Colorectal Dis 2006; 21:291-300.
7. Wong SC, Lo SF, Lee KC, Yam JW, Chan JK, Wendy Hsiao WL: Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumors. J Pathol 2002; 196:145-153.
8. Rajnakova A, Goh PM, Chan ST, Ngoi SS, Alponat A, Moochhala S: Expression of differential nitric oxide synthase isoforms in human normal gastric mucosa and gastric cancer tissue. Carcinogenesis 1997; 18:1841-1845.
9. Endo K, Terada T: Proteinexpression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression,and patient survival. J Hepatol 2000; 32:78-84.
10. Watanabe O, Imamura H, Shimizu T, Kinoshita J, Okabe T, Hirano A, et al: Expression of twist and wnt in human breast cancer. Anticancer Res 2004; 24:3851-3856.
11. Rhee CS, Sen M, Lu D, Wu C, Leoni L, Rubin J, et al: Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 2002; 21:6589-6605.
12. Kenny PA, Enver T, Ashworth A: Receptor and secreted targets of Wnt/beta-catenin signaling in mouse mammary epithelial cells. BMC Cancer 2005; 5:3.
13. Chen G, Shukeir N, Potti A, Sircar K, Aprikian A, Goltzman D, et al: Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastasis prostate carcinoma: potential pathogenetic and prognostic implications. Cancer 2004; 101:1345-1356.
14. Furuse C, Cury PR, Altemani A, dos Santos Pinto D, de Araújo NS, de Araújo VC: Beta-catenin and E-cadherin expression in salivary gland tumors. Int J Surg Pathol 2006; 14:212-217.
15. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251:1451-1455.
16. Jawhari A, Farthing M, Pignatelli M: The importance of the E-cadherin-catenin complex in the maintenance of intestinal epithelial homoeostasis is more than intercellular glue. Gut 1997; 41:581-584.
17. Moon KC, Cho SY, Lee HS, Jeon YK, Chung JH, Jung KC, et al: Distinct expression patterns of E-cadherin and beta-catenin in signet ring cell carcinoma components of primary pulmonary adenocarcinoma. Arch Pathol Lab Med 2006; 130:1320-1325.
18. Gulmann C, Grace A, Leader M, Butler D, Patchett S, Kay E: Adenomatous polyposis coli gene, beta-catenin, and E-catenin expression in proximal and distal gastric cancers and precursor lesions: an immunohistochemical study using tissue microarrays. Appl Immunohistochen Mol Morphol 2003; 11:230-237.
19. Zhou YN, Xu CP, Han B, Li M, Qiao L, Fang DC, et al: Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 2002; 8:987-993.
20. Zeng G, Germinaro M, Micsenyi A, Monga NK, Bell A, Sood A, et al: Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma. Neoplasia 2006; 8:279-289.
21. Mazieres J, He B, You L, Xu Z, Jablons DM: Wnt signaling in lung cancer. Cancer Lett 2005; 222:1-10.
22. Jawhari AU, Farthing MJ, Pignatelli M: The E-cadherin/epidermal growth factor receptor interaction: a hypothesis of reciprocal and reversible control of intercellular adhesion and cell proliferation. J Pathol 1999; 187:155-157.